What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

SELLAS Life Sciences Group, Inc. SLS EBITDA

EBITDA at other companies

Syndax PharmaceuticalsSNDX

-$30.2M+63.9%

ImmunomeIMNM

-$58.73M-33.4%

Arcus BiosciencesRCUS

-$132M-10.9%

Cogent Biosciences, Inc.COGT

-$102.98M-38.6%

PfizerPFE

——

AbbVieABBV

——

Other financials

Income statement

See full

Revenue-—

Gross profit-—

Operating income-$9.3M-52.6%

Net income-$8.4M-44.6%

EPS (diluted)-$0.05+28.6%

Balance sheet

See full

Cash & equivalents$107.1M+277%

Total debt$871.0K+0.1%

Total equity$107.4M+287%

Total assets$114.2M+227%

Cash flow

See full

Operating cash flow-$8.8M+2.5%

Valuation

See full

Market cap$1.8B+674%

Profitability

See full

Gross margin90%-7.4pp

Operating margin-4,195%-4,591pp

Net margin-4,130.1%-4,444pp

FCF margin-300.5%—

Returns & leverage

See full

Return on equity-43.6%-17.9pp

Debt / equity0×0.0×

Current ratio17.2×+12.6×

Where this comes from

Calculated from SELLAS Life Sciences Group, Inc.’s reported figures.

−$8.6Mebit+

$470.8KDepreciation Depletion & Amortization

=-$8.11M

The official record: SELLAS Life Sciences Group, Inc.’s 10-K, filed April 13, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.